… to pharmacokinetics of vancomycin in hospitalized patients … were to develop a population
pharmacokinetic model for … monitoring, including patients undergoing intermittent hemodialysis, …

… the population pharmacokinetics of gentamicin in a group of 939 adult hospitalized patients
… and to evaluate the potential influence of patient covariates on gentamicin disposition. Data …

… TZP on its pharmacokinetic (PK) profile has not been widely assessed. Here, we describe …
population pharmacokinetics for both piperacillin and tazobactam among hospitalized patients …

… Population pharmacokinetics and pharmacodynamics (PKPD) of linezolid Population
pharmacokinetics and pharmacodynamics analysis performed the population PK parameters and …

… The goal of this study was to build a population pharmacokinetic (PK) model to
characterize the population PK parameters in our hospitalized patients. Teicoplanin serum …

… The aims of this study are to describe the population PK (PopPK) of apixaban in a cohort
of hospitalized patients and to quantify the impact of intrinsic/extrinsic factors on apixaban …

… with a wide range of baseline characteristics, including hospitalization in ICU and non-ICU …
steady-state population pharmacokinetics of doripenem in obese, hospitalized patients and to …

… the population pharmacokinetics (popPK) and pharmacodynamics (PD) of high-dose levofloxacin
in a large sample of acutely hospitalized older patients in … in older patients with various …

… , this study presents the first population pharmacokinetic model based on both remdesivir
and GS-441524 concentrations in a cohort of hospitalized COVID-19 patients. In this cohort, …

… to describe the population pharmacokinetics of tobramycin in hospitalized patients. In addition,
since several factors have been shown to influence the pharmacokinetics of tobramycin, …